Valerie Start
Vermögen: 282 480 $ am 31.05.2026
Vermögen: 282 480 $ am 31.05.2026
Valerie Denise Harding Start currently works at Erasca, Inc., as Independent Director from 2019, Smallify LLC, as Member & Partner, and Start Pharma Consulting LLC, as Principal from 2019.
Dr. Start also formerly worked at Pfizer Inc., as Vice President-Product Differentiation in 2012 and Ignyta, Inc., as Senior VP-Chemistry, Manufacturing & Controls from 2015 to 2019.
Dr. Start received her undergraduate degree from the University of London and doctorate degree from The University of Nottingham.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ERASCA, INC. 0.01% | 26.06.2026 | 22’000 ( 0.01% ) | 282 480 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ERASCA, INC. | Direktor/Vorstandsmitglied | 01.06.2019 |
Start Pharma Consulting LLC | Corporate Officer/Principal | 01.02.2019 |
Smallify LLC
Smallify LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting, training, certification and tools to embed rapid innovation practices inside an organization | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| IGNYTA INC | Corporate Officer/Principal | 01.01.2019 |
| PFIZER INC. | Corporate Officer/Principal | 01.01.2012 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ignyta, Inc.
Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Erasca, Inc.
Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Smallify LLC
Smallify LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting, training, certification and tools to embed rapid innovation practices inside an organization | Commercial Services |
Start Pharma Consulting LLC |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen